Neurothera Labs Inc. (TSXV: NTLX)
Health Care · Pharmaceuticals · US
CA$0.33
+12.07% today · +62.5% 1Y
Neurothera Labs Inc. (TSXV: NTLX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $19.81M.
Over the last twelve months the share price has gained 62.5%, trading between 0.16 and 0.29.
Tweenvest scores Neurothera Labs Inc. across four factors: quality 25/100, value 70/100. Its strongest factor is value.
NTLX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.81M
- Revenue (TTM)
- $856.00K
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- -0.20
- 52-week high
- CA$0.29
- 52-week low
- CA$0.16
- Avg volume (3M)
- —
- Shares outstanding
- 84.90M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.